ACHV Earnings Preview: Options Price a ±25.2% Move
· The NYC Memo · ACHV reports 2026-11-05
Achieve Life Sciences, Inc. reports November 5, 2026. The December 18, 2026 straddle implies ±25.21% against a 7.43% average reaction, with dealers long gamma and max pain at $2.5.
Achieve Life Sciences, Inc. reports Q3 2026 results on November 5, 2026. The December 18, 2026 straddle is priced at $1.76, an implied move of ±25.21% against an average realised reaction of 7.43% over the last 8 prints. The stock trades at $6.98, -19.2% from its 52-week high, with dealers long gamma and max pain at $2.5.
What the options market is pricing
| Measure | Level |
|---|---|
| November 5, 2026 | |
| Expiry used | December 18, 2026 (43 days out) |
| Spot | $6.98 |
| ATM straddle | $1.76 |
| Implied move | ±25.21% ($5.22 to $8.74) |
| ATM implied vol | 91.8% |
| Put/call open interest | 0.01 |
| Max pain | $2.5 |
| Net dealer gamma | +$0.15mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $15 (10,025 contracts) |
| Heaviest put strike below spot | $5 (203 contracts) |
| Street EPS estimate | $-0.20 |
| Street revenue estimate | $0.00bn |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ACHV between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Aug 11 | -1.18% |
| Q1 2026, May 12 | +7.16% |
| Q4 2025, Mar 24 | -28.40% |
| Q3 2025, Nov 6 | -3.85% |
| Q2 2025, Aug 7 | +0.00% |
| Q1 2025, May 13 | +6.85% |
| Q4 2024, Mar 11 | -4.58% |
| Q3 2024, Nov 7 | -7.40% |
Across the last 8 prints the average absolute reaction is 7.43%, with 2 higher and 5 lower. The best was +7.16% and the worst -28.40%. Options are asking ±25.21%, which is 17.78 points richer than the realised average, the premium seller's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $6.98 |
| 52-week range | $2.62 to $8.64 |
| Position in that range | 72% |
| From the 52-week high | -19.2% |
| From the 52-week low | +166.4% |
| Past week | +1.9% |
| Past month | -0.7% |
| Past three months | +6.6% |
| 50-day average | $7.38 |
| 200-day average | $5.66 |
How the options market is pricing it
The December 18, 2026 straddle marks $5.22 to $8.74 as the range the options market is paying for into the print, with ATM implied vol at 92% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ACHV has moved 7.43% on earnings against the ±25.21% now implied, so the market is pricing this print richer than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ACHV before the print.
Data as of November 5, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ACHV options memo